Sputnik V shows strong protection against Omicron

Russia's Covid-19 vaccine Sputnik V has demonstrated strong protection against the Omicron variant of the virus compared to the Pfizer vaccine, according to a study conducted at the Spallanzani Institute in Italy in collaboration with investors in the Sputnik vaccine.

As per the report, a comparative study shows that the Sputnik V coronavirus vaccine demonstrates more than two times higher titers of virus-neutralizing antibodies to Omicron variant than two doses of Pfizer vaccine (2.1 times higher in total and 2.6 times higher three months after vaccination).

The study demonstrates that Sputnik V neutralizes the Omicron variant by inducing robust antibody response associated with high levels of protection, reads the report. The hard scientific data proves Sputnik V has higher virus-neutralizing activity against Omicron as compared to other vaccines and will play a major role in the global fight against this new contagious variant, said Alexander Gintsburg, Director, GamaleyaNational Research Center for Epidemiology and Microbiology, Russia.